Related Experiment Video

Updated: Jun 26, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance

Olivia Simma1, Eva Zebedin, Nina Neugebauer

  • 1Institute of Pharmacology, Medical University of Vienna, Waehringerstrasse 13A, Vienna, Austria.

Cancer Research
|January 2, 2009
PubMed

Insights

Tyrosine kinase 2 (Tyk2) is crucial for T cell-mediated tumor surveillance. Tyk2 deficiency impairs cytotoxic T lymphocyte (CTL) function, leading to faster tumor growth and reduced survival in mice.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Signaling

Background:

  • Tyk2(-/-) natural killer cells exhibit impaired leukemic cell lysis, predisposing mice to leukemia.
  • The role of Tyk2 in T cell-mediated tumor surveillance remained to be fully elucidated.

Purpose of the Study:

  • To investigate the role of Tyrosine Kinase 2 (Tyk2) in T cell-mediated tumor surveillance.
  • To determine the specific signaling pathways involved in Tyk2-dependent anti-tumor immunity.

Main Methods:

  • Utilized Tyk2(-/-) mice and OT-1 transgenic mice challenged with EL4 thymoma and ovalbumin-expressing EG7 tumor cells.
  • Performed in vivo cytotoxicity assays and adoptive transfer experiments.
  • Investigated the involvement of Type I Interferon (IFN) signaling by comparing Tyk2(-/-), IFNAR1(-/-), IFNgamma(-/-), and IL12p35(-/-) mice.

Main Results:

  • Tyk2 deficiency significantly decreased disease latency in EL4 thymoma models.
  • Tyk2(-/-) OT-1 mice exhibited faster EG7 tumor growth compared to wild-type controls, confirming a defect in CD8(+) cytotoxicity.
  • Impaired CTL activity was specifically linked to Type I IFN signaling, as it was observed in Tyk2(-/-) and IFNAR1(-/-) mice but not in IFNgamma(-/-) or IL12p35(-/-) mice.
  • Adoptive transfer of Tyk2(-/-) OT-1 T cells failed to control EG7 tumor growth, highlighting Tyk2's essential role in CTL-mediated surveillance.

Conclusions:

  • Tyk2 is essential for effective T cell-mediated tumor surveillance.
  • Type I IFN signaling is critical for Tyk2's function in cytotoxic T lymphocyte (CTL) activity against tumors.
  • Tyk2 deficiency compromises anti-tumor immunity by impairing CTL function, particularly through the Type I IFN pathway.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...